share_log
Reuters ·  Aug 6 05:00
First Patient Enrollment in the U.S. - a Milestone for the Global Multi-Center Phase Ⅲ Clinical Trial of Telitacicept for Myasthenia Gravis
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment